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ABSTRACT
SRSF2 is a prototypical SR protein which plays
important roles in the alternative splicing of
pre-mRNA. It has been shown to be involved in
regulatory pathways for maintaining genomic
stability and play important roles in regulating key
receptors in the heart. We report here the solution
structure of the RNA recognition motifs (RRM)
domain of free human SRSF2 (residues 9–101).
Compared with other members of the SR protein
family, SRSF2 structure has a longer L3 loop
region. The conserved aromatic residue in the
RNP2 motif is absent in SRSF2. Calorimetric titration
shows that the RNA sequence 50AGCAGAGUA30
binds SRSF2 with a Kd of 61 ± 1 nM and a 1:1 stoichi-
ometry. NMR and mutagenesis experiments reveal
that for SFSF2, the canonical b1 and b3 interactions
are themselves not sufficient for effective RNA
binding; the additional loop L3 is crucial for RNA
complex formation. A comparison is made
between the structures of SRSF2–RNA complex
with other known RNA complexes of SR proteins.
We conclude that interactions involving the L3
loop, N- and C-termini of the RRM domain are col-
lectively important for determining selectivity
between the protein and RNA.
INTRODUCTION
Constitutive and alternative splicing are inﬂuenced by
splicing factors such as the Serine Arginine (SR) family.
SR proteins are made up of one or two N-terminal RNA
recognition motifs (RRM) domains followed by a
C-terminal RS domain. RNA binding domains or RRM
(RBD) consists of a 90 amino acids domain
comprising a 4-strand anti-parallel b-sheet connected to
two a-helices (1).
SR proteins exhibit dual functionality in constitutive
and alternative splicing. In constitutive splicing, the SR
proteins appear to interact with the RNA in a non-speciﬁc
manner. However, in alternative splicing, the SR protein
family has differing RNA binding speciﬁcities that play an
important role in splice site selection and regulation (2).
Although the mechanisms behind the different functions
of these proteins in the two splicing actions are not yet
fully understood, it is known that the regulation of alter-
native splicing relies upon the interaction of SR proteins
with RNA regulatory sequences. These sequences, known
as ESEs, ISEs, ESSs and ISSs (exonic splicing enhancer,
intronic splicing enhancers, exonic splicing silencers and
intronic splicing silencers, respectively) provide the mech-
anism by which exon skipping is prevented, ensuring the
correct order of exonic sequences in the spliced messenger
RNA (mRNA) (3). Regulatory RNA sequences are
involved in both constitutive and, to a greater extent, al-
ternative splicing, to enable the assembly of a functional
spliceosome at the correct splice site (4).
The SR protein Serine/Arginine-rich Splicing Factor 2
(SRSF2), previously known as SC35, is a prototypical SR
protein, involved in splicing proteins essential for a
number of pathways. In the thymus and pituitary
glands, SRSF2 functions during organ development
where it is an integral part of regulatory pathways main-
taining genomic stability (5,6). In the heart, SRSF2 plays
an important role in regulating key receptors essential for
heart function (7) and hypoxic hearts have been shown to
trigger SRSF2 phosphorylation, which is surmised to
counteract heart damage (8). SRSF2 has also been
shown to work antagonistically to SRSF1 (9) and also
compete with SRSF6 (10). The recurring theme through-
out the studies of SRSF2 is that SRSF2 is involved in
pathways that require tight control and regulation and
SRSF2 expression is self-regulated by a negative
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feedback loop. Self-regulation occurs by SRSF2 splicing
its own pre-mRNA to introduce premature stop codons
which bring about destruction of the pre-mRNA by the
nonsense-mediated mRNA decay pathway (NMD) (11).
Furthermore the antagonistic effect of SRSF2 is activated
by several low-afﬁnity exon–SRSF2 interactions (12).
The speciﬁcity of the differing SR proteins for distinct
RNA sequences has been probed in detail by a number of
groups. SRSF2 binding RNA sequences have been
identiﬁed by Systematic Evolution of Ligands by
Exponential Enrichment (SELEX) (13,14). Several se-
quences identiﬁed by this method were found to have
high binding afﬁnity although the Exon Splicing
Enhancer (ESE) activity was low (13,15). Furthermore it
is proposed that the binding of ESE is necessary but not
sufﬁcient to promote splicing and an additional cofactor is
also required (12). It is apparent that understanding the
molecular detail of the interactions between protein and
RNA is essential to interpret some of the nuances between
binding and activity.
The only known SR protein–RNA complex structure is
of SRSF3 (previously known as Srp20) in complex with a
four nucleotide RNA fragment (16). In the case of SRSF3
the consensus RNA sequence from SELEX yielded the
CAUC sequence that was then used to determine the re-
sultant structure. The nature of the complex was found to
be semi-speciﬁc with only the 50 cytosine selectively
recognized by speciﬁc interactions to b-strand 4 whereas
the other three nucleotides were shown to interact indis-
criminately with aromatic amino acids on the exposed
surface of the b-sheet.
Here we report the Nuclear Magnetic Resonance
(NMR) structure of the RRM domain of SRSF2.
Utilizing intermolecular Nuclear Overhauser Effects
(NOEs) and chemical shift mapping in conjunction with
mutagenesis and RNA–protein cross-linking, we also
probed the RNA binding speciﬁcity of SRSF2. From the
speciﬁc interactions identiﬁed we have determined that the
long ﬂexible loop between b-strands two and three (loop
3) plays an essential role in stabilizing the interaction of
the 50-end of the RNA (adenine 1 and guanidine 2) whilst
the ﬂexible C-terminus interacts with the RNA toward the
30-end (Uridine 8).
MATERIALS AND METHODS
Cloning, expression and puriﬁcation of SRSF2 RRM
domain
The DNA encoding the RRM domain (amino acids
9–101) of human SRSF2 was subcloned into pET-24b
containing the 58-amino acids GB1 solubility enhance-
ment tag and a 6 His tag. Point mutations were per-
formed by quick change mutagenesis using Pfu Turbo
(Stratagene). Oligonucleotide sequences will be provided
on request. GB1-His6-SRSF2 RRM (hereafter referred to
as SRSF2 RRM) was expressed in Escherichia coli BL21
Acella (EdgeBio). For labeled samples, expression was
carried out in M9 minimal media containing 15NH4Cl
and [13C6]-D-Glucose. Cells were grown at 37
C from a
single colony to an OD600 of 0.8 at which point the
cultures were transferred to 4C for 30min, then
returned to 30C and allowed to equilibrate for a further
30min. Expression of SRSF2 RRM was then induced by
1mM IPTG followed by incubation at 30C for 3 h.
SRSF2 RRM was puriﬁed by nickel afﬁnity chromatog-
raphy using a 6.4ml HIS-Select column (Sigma-Aldrich),
and eluted from the column with 50mM sodium phos-
phate, pH 8, containing 0.3M NaCl and 200mM imid-
azole. The concentration and purity of the eluted protein
were measured using a Bradford protein concentration
assay and SDS–PAGE analysis. The fractions containing
the eluted protein were dialyzed against H2O, lyophilized
and stored at 80C until required.
Structure determination of SRSF2 RRM and
relaxation measurements
NMR spectra of 0.5mM SRSF2 RRM in 25mM sodium
phosphate, pH 6.8, containing 100mM NaCl, 2mM DTT
and 0.02% NaN3 were recorded at 305K on Bruker
Avance 600 and 800MHz spectrometers equipped with
[1H, 15N, 13C]-cryoprobes. Data were processed using
TopSpin (Bruker) and analyzed using CCPN Analysis
(17). Sequence-speciﬁc backbone and side-chain resonance
assignment of SRSF2 RRM was made using 3D HNCA,
HN(CA)CB, HN(CO)CA, HNCO, CBCA(CO)NH,
HBHANH, HBHA(CO)NH and HCCH-TOCSY experi-
ments. Assignment of aromatic side-chain residues was
made using 2D [1H-13C] HSQC and homonuclear
1H NOESY and TOCSY spectra recorded in both D2O
and H2O.
The Ha, Ca, Cb and CO chemical shifts were analyzed
to give secondary structural information from the
chemical shift index (CSI, 18). The structural analysis of
SRSF2 RRM was performed using CYANA 2.1 software
(19), with input data of shift lists derived from 15N- and
13C-HSQC spectra, along with un-assigned NOESY peak
lists and additional restraints from 34 hydrogen bonds and
114 j and c torsion angles produced by TALOS (20).
CYANA 2.1 was run with standard protocols using
seven cycles of automated NOE assignment and structural
calculations, producing 100 structures per cycle. Of these
100, the 20 with the lowest target function were retained
for analysis. The best 20 structures from CYANA 2.1 were
further reﬁned in ARIA 1.2 (21) using a total of 3406
unambiguous interproton distance restraints. A ﬁnal
ensemble of the best 20 water-reﬁned structures was
selected on the basis of lowest energies, and was
characterized with PROCHECK-NMR (22) using the
iCing interface (http://nmr.cmbi.ru.nl/icing/iCing.html).
Atomic coordinates and NMR restraints of GB1-SRSF2
RRM have been deposited in the Protein Data Bank
under the accession code 2KN4.
Structural analysis employed NACCESS (http://www
.bioinf.manchester.ac.uk/naccess/) for identiﬁcation of
exposed hydrophobic residues, CCP4MG (23) for calcula-
tion and displaying electrostatic surface potentials, and
Pymol (The PyMOL Molecular Graphics System,
Version 1.3, Schro¨dinger, LLC) for secondary structure
and side chain analysis. In addition comparative analysis
of SR family employed promals3D (24) for secondary
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structure driven sequence alignment and Multiprot (25)
for homologous structure alignment.
15N R1, R2 and
15N{1H}-NOE experiments were
carried out on a Bruker Avance 600MHz spectrometer
at 298K with a uniformly labeled 15N sample of
SRSF2–RRM and conventional techniques with incorp-
oration of gradient selection and sensitivity improvement
(26). Heteronuclear 15N longitudinal (T1) and transverse
(T2) relaxation rates were obtained by two-parameter ﬁt
of the experimental peak intensities to the equation
I(t)= I0exp(t/T). The [1H]-15N-heteronuclear NOEs
were calculated from the ratio of peak intensities in
1H-saturated and unsaturated spectra.
Cross-linking of SRSF2 RRM with RNA
The RNAs GAGUA and AGCAGAGUA were
synthesized, puriﬁed by PAGE and identiﬁed by HPLC
by Dharmacon and Sigma-Aldrich (UK), respectively.
Unless otherwise stated, all RNA and protein samples
for NMR and ITC experiments were suspended in
25mM N-(2-Acetamido)-2-aminoethanesulfonic acid
(ACES), pH 6.8, containing 25mM NaCl, 0.2mM
TCEP and 0.02% NaN3, and then dialyzed individually
against the same buffer to ensure identical buffer condi-
tions for all samples. RNA cross-linking was carried out
as described previously (27).
Isothermal titration calorimetry
Isothermal Calorimetry was carried out on puriﬁed
samples of protein exchanged into 25mM ACES buffer
contain 25 or 200mM KCl using a NAP25 desalting
column (GE Healthcare). In order to handle the RNA
as little as possible HPLC puriﬁed lyophilized material
was directly resuspended in the required buffer and pH
adjusted where necessary. Control experiments whereby
the RNA was titrated into buffer and buffer into protein
exhibited undetectable heat exchange, conﬁrming that
there was appropriate match of buffer conditions with
no evidence of dilution effects. To maintain consistency
between titrations the same stock buffer was used in all
protein and RNA preparations. Experiments were con-
ducted at 25C with an ITC200 (GE Healthcare) with a
60 ml syringe volume and 200 ml cell capacity. Titrations
were carried out using between 2 mM and 200 mM of
protein in the cell and a 10-fold concentration of RNA
(between 20 mM and 2mM). RNA was added into the cell
in sequential 1 ml injections (at a rate of 0.5 ml/s) with a
180-s interval between each injection. One site (three par-
ameters) and two site (six parameters) curve ﬁtting was
carried out using the MicroCal-supported ITC module
within Origin version 7.
NMR experiments of SRSF2–RNA complex
15N-HSQC NMR titration experiments were carried out
on a Bruker Avance 800MHz spectrometer equipped with
a 5mm Cryoprobe at an experimental temperature of
305K. Initial conditions indicated that lowering salt con-
centration improved binding and therefore optimal
binding conditions were found to be 50mM ACES
buffer pH 6.8; negligible change to SRSF2 RRM spectra
led us to conclude that these buffer modiﬁcations had
minimal effects on protein structure. The RNA AGCAG
AGUA was titrated from zero to a ﬁnal concentration of
2.5mM RNA in 0.5mM SRSF2 RRM by mixing two
protein samples of different concentrations of RNA in
order to ensure no buffer mismatch or sample dilution.
The peaks in each HSQC were assigned in the CCPN
software.
RNA assignment
Natural abundance 1H 13C HSQC and homonuclear 2D
TOCSY and NOESYs (300ms mixing time) were collected
to assign the 9-mer RNA in 50mMACES buffer pH 6.8 at
305K through well-established methods (28). Lack of
base-ribose H10 sequential residues indicate that the
RNA in isolation does not have a well deﬁned structure.
Protein–RNA complex modeling
The assignments of both the RNA and SRSF2 RRM in
the complexed forms were obtained by tracking chemical
shifts during an RNA titration. Several types of spectra
were collected: 1D 1H spectra, natural abundance 2D 1H
13C HSQC (for RNA shifts) and 1H 15N/1H 13C HSQC
using labeled SRSF2. Intermolecular NOEs between
15N,13C labeled SRSF2 RRM and unlabeled RNA were
collected using ﬁltered NOESY experiments (29) with
unlabeled RNA at a 5-fold excess and a mixing time of
300ms. We modeled the SRSF2–RNA structure using two
different approaches, HADDOCK (High Ambiguity
Driven biomolecular DOCKing) (30,31) and CNS (32).
For both protocols, ambiguous interaction restraints
were deﬁned by RRM residues which showed chemical
shift perturbations of higher than 0.15 ppm or whose
mutation led to loss of RNA binding. For the RNA,
active residues were deﬁned based on chemical shift
changes upon binding to SRSF2. Experimental intermo-
lecular NOEs between the RRM domains and RNA were
also included. The RNA structure was poorly deﬁned due
to a lack of intramolecular NOEs. As the HADDOCK
method works best when the individual interacting com-
ponents have well-deﬁne structures, the HADDOCK-
derived structures did not satisfy all the experimental
intermolecular NOEs, this possibly due to the limited con-
formational space sampled by the ensemble of random
coil RNA coordinates. Simulated annealing using the
CNS software allowed a ﬂexible treatment of the RNA
coordinates and was performed with the protein restraints
employed for the calculation of the GB1-SRSF2 structure,
together with the six intermolecular RRM-RNA NOEs.
After the ﬁrst iteration of structures, it was apparent that a
distance restraint between the conserved F57 and F59 to
the RNA C3 could be included based on the proximity of
the cystidine to both phenylalanines and the consensus of
p stacking of these amino acids in homologous structures.
The ﬁnal ensemble of the best 20 water-reﬁned structures
was selected on the basis of lowest energies and without
intermolecular NOE violations. The clusters were
analyzed using criteria deﬁned in the HADDOCK
program. Pairwise RMSD analysis of these structures
was carried out to deﬁne clusters of models with overall
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RMSD of 5 A˚ or less based on alignment of backbone
atoms of the RNA 9-mer and the secondary structure
elements of SRSF2.
RESULTS
SRSF2 RRM domain is completely independent of
GB1 solubility tag
The RRM structure of SRSF2 was determined in the
presence of the N terminally tethered GB1 fusion
protein, the latter being essential to keep the protein in
solution (33). The fusion protein is monomeric in solution
with a molecular mass of 16 kDa as assessed by
size-exclusion chromatography and multi-angle light scat-
tering analysis (data not shown). The RMSD (using
backbone atoms Ca, NH, C0) for the RRM over the 20
lowest energy structures was 0.5 A˚ (Table 1 and Figure 1).
T1 T2 and heteronuclear NOE analysis of the SRSF2
RRM construct demonstrated the lack of interaction
between the two domains (Supplementary Figure S1);
the T1/T2 values for the RRM and GB1 domain indicate
different rotational correlation times for the two domains,
with the T1/T2 values of GB1 fused to SFSR2 being
similar to those of isolated GB1, which suggests that the
RRM domain has very little effect on the solution reorien-
tation of the GB1 domain. The lack of interdomain NOEs
between the two domains also corroborates the autonomy
of the two separate domains. Comparison of the structure
of GB1 determined here and in isolation (PDB number
2IGG; BMRB Accession number 1639) showed that the
two structures are similar, further conﬁrming that the
presence of the RRM domain had negligible inﬂuence
on the GB1 tag. The chemical shifts of GB1 alone and
fused to the RRM are identical under the same buffer
conditions. We, therefore, conclude that the two folded
domains are completely independent of each other and
do not have any artefactual interactions.
The structure of SRSF2 RRM domain comprises a four
strand anti-parallel b-sheet and two a-helices. The highly
ordered secondary structure elements are apparent in the
ensemble of structures (Figure 1B) with a signiﬁcant
degree of ﬂexibility in the apical loop 3 between strands
2 and 3 as inferred from 1H{15N} heteronuclear relax-
ation, Random Coil Index (34) data (Supplementary
Figure S1), and a lack of intramolecular proton NOEs
for this region of the protein. The N- and C-termini are
ﬂexible as evident from the chemical shift values and the
lack of long-range NOE correlations. Due to signiﬁcant
resonance overlap of resonances for the C-terminal region,
reliable 15N relaxation data could only be obtained for the
N-terminus residues, which show low-frequency motions
that are associated with conformational exchange. The
compact, well-ordered structure is maintained by extensive
hydrogen bonds in the b-sheet together with a buried,
internal hydrophobic core formed by residues L30, F34,
A68, A71 and M75 of the two a-helices and residues on
the inward face of the b-sheet, L16, V18, V40, V43, I45,
A58, V60, F62, L85 and V87. In addition to the hydro-
phobic core, NACCESS analysis revealed two
surface-exposed hydrophobic patches on opposite sides
of the protein. On the outward face of the b-sheet Y44
of strand 2 and F57, F59 of strand 3 create a hydrophobic
patch with C-terminus residue Y92 and loop 3 residues
Y50 and T51. On the helical side of the protein, a
second hydrophobic patch comprises helical residues
V33 Y37 M72 and A74 together with loop 1 residues
T22, Y23 and loop 5 residues V79 and G82.
Structure of SRSF2 RRM domain is typical of the
SR family
The structure of the SRSF2 RRM domain resembles the
classical fold for RRM domains with the C terminal
residues exhibiting a greater degree of ﬂexibility. In com-
parison with the homologous SR RRM domains, SRSF2
aligns well, in particular, with the single or ﬁrst RRM
domains (Figure 2A). When RRMs occur in tandem in
SR proteins the second RRM domain has an extended
loop 5 and is shown to bind RNA in a different manner
to the ﬁrst/single RRM domains (27,35). Therefore, a
comparison of existing SR RRM domains has been
carried out exclusively on single/ﬁrst RRM structures
(Figure 2B). The aligned RRM domains adopt a highly
homologous structure with a RMSD of the structured
regions of 1.21 A˚ (over the 58 backbone residues indicated
in the alignment). However, differences are apparent in
the ﬂexible N and C termini and also the hairpin loop
L3 between b2 and b3, which varies in length between
the RRM domains.
Table 1. NMR statistics for the structure of SRSF2 RRM
Experimental restraints
Restraints
Unique/Ambiguous NOEs 3406/145
Intraresidue 1441/43
Sequential 735/29
Short range (1< [i  j] <5) 379/23
Long range ([i  j] >4) 851/50
j/c dihedral anglesa 114
Energies (kcal mol1)b
Total 5948±80
Van Der Waals 1370±17
NOE 78±23
RMS deviationsb
NOEs (A˚) (no violations >0.5 A˚) 0.02±0.003
Dihedral restraints () (no violations >0.5 A˚) 0.44±0.09
Bonds (A˚) 0.0040±0.0001
Angles () 0.51±0.02
Impropers () 1.55±0.07
Ramachandran map analysisc (%)
Allowed regions 80.2
Additional allowed regions 15.5
Generously allowed regions 2.6
Disallowed regions 1.7
Pairwise rms difference (A˚)d
Residues 70–146 1.31 (2.13)
2o Structure 0.40 (0.99)
aFrom chemical shifts using Talos.
bCalculated in ARIA 1.2 for the 20 lowest energy structures reﬁned in
water.
cObtained using PROCHECK-NMR.
dFor backbone atoms; value for all heavy atoms in brackets.
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RRMs of SR proteins possess classic ribonucleoprotein
(RNP) recognition motifs, RNP1 and RNP2, on b3 and
b1 strands, which are essential for RRM–RNA inter-
actions (1), although the degree of hydrophobicity in b1
is reduced in SRSF2 and SRSF3. The RNP1 sequence is
conserved in SRSF2, with core conserved amino acids on
b3 being F57 and F59 (Figure 2A). However, the aromatic
residue that is normally found in b1, and which is import-
ant for RNA binding, is missing in SRSF2, this being
replaced by a lysine residue (K17).
Comparison of electrostatic surface potential and
hydrophobic surfaces show non-polar areas differ
between SR-RRMs, with SRSF2 having a marginally
greater area of exposed hydrophobic residues in L3
(Supplementary Figure S2). In the SRSF3 RRM structure,
the corresponding residues for the b-sheet outward face
hydrophobic patch are Y13, G15, W40, A41, F48, F60,
L80, with P45, G47, of loop 3 and G83 of the C-terminus
region; Y50 and T51 found in SRSF2 RRM do not exist
in SRSF3 RRM. On the helical side, the corresponding
residues in SFSR3 are T24, G31, Y32, P35 P56, A60 G68,
T70, L71, G73 (Supplementary Figure S2).
Binding of SRSF2 RRM to RNA using NMR and
mutagenesis
Various RNA constructs were used to probe the nucleo-
tide speciﬁc interactions of SRSF2. SELEX analysis has
previously identiﬁed several sequences which preferen-
tially bind SRSF2 (13). For the purpose of this study we
focused primarily on the GAGUA SELEX motif and
found this 5-mer bound preferentially over non-speciﬁc
sequences such as AUAUA (Supplementary Figure S3).
However, NMR chemical shift mapping yielded an ap-
proximate Kd in the order of 0.5mM. By extending the
50-end of GAGUA to give a 9-mer construct, AGCAGAG
UA, the RNA bound with higher afﬁnity to SRSF2, as
assessed initially by NMR. This complex was taken
forward for further studies.
Figure 1. (A) SRSF2 RRM sequence and secondary structure. (B–E) Structure of SRSF2 RRM: (B) ensemble structures. (C) cartoon representation
and schematic colored blue to red N-terminus to C-terminus, loops, strands and helices labeled according to RRM consensus (1). (D) electrostatic
surface (red 5, blue +5). (E) hydrophobic residue analysis of SRSF2 identiﬁed two surface exposed patches, one on the helical face (yellow) the
other on the b-sheet face (cyan); the hydrophobic core of the molecule comprises residues from both helices (magenta) and strands (red), for clarity
ﬂexible C-terminus residues 94–101 are omitted.
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The 9-mer RNA lacks internucleotide NOEs, suggesting
that the RNA is largely unstructured in the unbound state.
Titration of RNA into 15N-labeled protein causes large
chemical shift changes and/or line-broadening to many
resonances in the 1H-15N HSQC spectrum, suggesting
that a large number of residues in the protein are
affected by RNA binding (Figure 3 and Supplementary
Figure S4). The resonances of the RNA bases also show
signiﬁcant shift changes and/or line broadening upon
interaction with SRSF3.
The mixture of the resonance characteristics (shifts and
line-broadening) over the course of the RNA titration is
not unusual, as often observed for many protein–ligand
titrations. Typically, for a given equilibrium, while the
overall exchange rate constants are indeed constant, dif-
ferent resonances will show different exchange behavior
on the NMR timescale, as revealed in the differences in
the degree of line-broadening, depending on the total
chemical shift change (vtotal) between the free and
bound states. Deriving dissociation constant values (Kd)
from NMR titrations is only reliable under conditions of
extreme fast exchange on the NMR timescale (and hence
very weak binding). For SRSF2, since fast exchange was
not universally observed for all the resonances, dissoci-
ation constants for the 9-mer could not be reliably ex-
tracted from the NMR titrations. However, despite
severe attenuation for some of the peaks, it was possible
to obtain the resonance assignment of the bound protein
and RNA since chemical shift changes could be followed
over the course of the titration.
The resonance perturbation of the protein spectrum
enabled the RNA-binding region of SRSF2 RRM to be
mapped and key residues identiﬁed. When compared with
GAGUA (and the non-speciﬁc control AUAUA), more
extensive shift changes and of larger magnitudes are
observed (Supplementary Figure S3), suggesting that the
extra nucleotides increase the number of protein–RNA
contacts. This is corroborated by the intermolecular
NOE data (see later). Analyses of the resonance per-
turbations show that amino acids from three regions
of the RRM domain are signiﬁcantly affected by
RNA binding: the N-terminus leading into b1, namely
residues V10, M13 and T14; residues D48, T51, K52 and
E53 of the long ﬂexible L3 loop; and residues L16,
D42, V43, Y44, I45, V60 and R61, comprising the
b-sheet formed by b1, b2 and b3 (Figure 3 and
Figure 2. Alignment of the SR protein RRM domains. (A) PDB deposited structures colored according to overlay and identiﬁed by PDB number
and name, all other RRMs colored grey and identiﬁed by uniprot number and name. Conserved residues for RNA binding are highlighted in yellow
(B) Left: Overlay of backbone atoms of the molecular structures of all known SR RRM domains, backbone alignment using 57 residues (indicated in
by dots beneath the sequence) with an RMSD of 1.18 A˚. Structures shown of human SR family RRM domains; SRSF1 (1X4A–RSGI), SRSF2B
(2DNM–RSGI), SRSF7 [2HVZ (16)] and SRSF3 [2I2Y, 2I38 (16)]. Right: Cartoon representation of structures; for clarity only two SR–RRM
domains are shown; SRSF2 and SRSF3, the SRSF3 structure used for this alignment is from PDB ID 2I2Y, the only SR–RRM structure determined
in the presence of RNA.
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Supplementary Figure S4). In addition, line broadening
upon RNA titration of the L3 loop residue R49,
supports the notion that these regions are interacting
with the RNA. In addition to probing the backbone NH
resonances of SRSF2 RRM, the 13C side chain resonances
were also monitored throughout the RNA titration. Large
side chain shifts were identiﬁed for the aromatic rings of
F57 and F59 in b3, the methyl groups of V10, M13 at the
N-terminus and also V60 in the L3 loop (Supplementary
Figure S5). The chemical shift data show that SRSF2
RRM domain, like most RRM domain, binds RNA
using the b-sheet. In addition, however, resonances
from the L3 region appear to be signiﬁcantly perturbed
(Figure 3).
We attempted to obtain information on intermolecular
contacts between the RRM domain and the RNA by
acquiring 13C, 15N-ﬁltered NOE data using a 13C,
15N-labeled SRSF3-RNA complex sample, although
only a limited number of contacts are observed. From
the SRSF2:AGCAGAGUA complex, four intermolecular
NOEs could be assigned to speciﬁc residues; these
involved NOEs from residues in the L3 loop, the N and
C-termini, namely between V10-Ade6, D48-Gua2,
Y50-Gua2 and Y92-Uri8 (Figure 6A). The intermolecular
NOEs agree well with the chemical shift mapping data
(Figure 3). From the speciﬁc interactions identiﬁed, we
determine that the long ﬂexible loop L3, between b2 and
b3, plays an essential role in stabilizing the interaction
with the RNA 50-end (Adenine 1 and Guanidine 2),
whereas the ﬂexible C-terminus interacts with the RNA
toward the 30-end (Uridine 8).
The number of intermolecular contacts is small. One
possible explanation is the severe chemical exchange
line-broadening of some of the residues at the protein–
RNA binding interface. Of those observed, most are
from regions of high ﬂexibility in the SRSF2 structure—
the L3 loop region, and the N- and C-termini. Detection
of these intermolecular NOEs suggests that the inter-
actions involving these regions are signiﬁcantly long-lived
rather than transient. However, the limited number of
intermolecular contacts, plus the fact that these are
between poorly structured, ﬂexible regions of both the
SRSF2–RRM and the RNA, precluded the calculation
of a high-resolution structure of the complex.
To probe the importance of the L3 region, several
mutants were generated. Being in the loop region, these
mutations have minimal effects on the integrity of the
RRM fold, as conﬁrmed by the 1H-15N HSQC spectra
of the mutants. These spectra show that the mutant
proteins are folded, with minimal shift changes
compared to the wild-type spectrum, and these conﬁned
mainly to the sites of mutation (Supplementary Figure
S6). Hence, any effects on the afﬁnity of the RNA to the
mutant proteins are the results of the speciﬁc mutation.
RNA binding was assayed by UV cross-linking
(Figure 4). The mutated amino acids with the most
pronounced effect were K52, the double mutant
R47-D48 and the triple mutant R47, D48, T51. These
results unambiguously demonstrate the importance of
the mutated residues in mediating RNA binding. That
the loop mutations cause the most dramatic decrease in
RNA binding afﬁnity compared to the wild-type protein
suggests that, in the case of SRSF2–RRM, the canonical
b1 and b3 interactions (1) found in typical RRM:RNA
binding are themselves not sufﬁcient for effective
RNA binding; the additional loop L3 is crucial for
RNA complex formation.
Binding of SRSF2 RRM to RNA by isothermal
titration calorimetry
The 5-mer GAGUA SELEX motif bound too weakly and
was unsuitable for ITC investigations. Isothermal calori-
metric titrations using the 9-mer give a good binding curve
and showed that the binding is exothermic (Figure 5).
Figure 3. Histogram of chemical shift changes—residues with combined shifts greater than 0.15 ppm (orange) and 0.25 ppm (yellow) marked on
structure inset. Filled circle represents NH peak not assigned, open circles represent peaks that broaden or cannot be tracked upon titration and
asterisks represent overlapping NH peaks. Signiﬁcant shift changes/line-broadening can be seen for residues in the b-strands as well and residues in
L3, in particular residues Y50 and T51, and the N-termini.
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Fitting the calorimetry curve to a one site model yielded
good thermodynamics parameters The 9-mer binds with a
stoichiometry of 1:1 and a dissociation constant, Kd, value
of 61 nM (Figure 6), with a large negative enthalpy, H,
of 21 kcal/mol and change in entropy, S, of approxi-
mately 38.4 calmol1K1 (at 298K). The same experi-
ments repeated at 200mM KCl gave a Kd value of
1.36mM, H, of 26 kcal/mol and change in entropy,
S, of 60.6 calmol1K1, with a reduction in the minor
non-speciﬁc initial interactions observed at low salt
concentrations (36) (Supplementary Figure S7). The
enthalpy-driven interactions accompanied by large heat
of associations are not dissimilar to many protein–RNA
interactions. The salt dependence of the RNA binding
suggests the presence of electrostatic interactions
between SRSF2 and the 9-mer.
A comparable binding curve, albeit weaker binding, is
obtained for the single point mutant K52A, with a Kd
value of 170 nM at 25mM KCl, and a binding stoichi-
ometry of 1:1, a negative enthalpy of 29.4 kcal/mol and
S of 67.7 calmol1K1 at 298K (Figure 5). The same
experiments repeated at 200mM KCl gave a Kd value of
3.6mM. The effects of KCl on the mutant protein inter-
actions are similar to those of the wild-type protein. This
suggests that apart from electrostatic interactions, the
other types of interactions such as aromatic ring
stacking and hydrogen bonds are also likely to be import-
ant in the SRSF2–RNA complex. The dissociation
constant for the R47-D48 double mutant was too weak
to be measured by ITC.
Comparison of SRSF2–RNA interactions with SRSF3
RRM:CAUC
The binding of SRSF3 to 4-mer CAUC relies on p
stacking interactions between amino acids Y13, F50 and
F48 across the b-sheet to C1, A2 and U3, respectively (16);
in this complex, the aromatic side-chains of these residues
and the RNA nucleotide bases formed a very compact
network of hydrophobic interactions. In the case of
SRSF2 these positions on the b-sheet are occupied by
aromatic residues F57 and F59 and are involved in
binding, as evident from the 1H-13C-chemical shift;
however, the residue corresponding to Y13 is the basic
residue K17. The NMR chemical shift mapping data
show K17 not to be signiﬁcantly affected by the binding
of the RNA. Given that the structure of SRSF3:CAUC is
already known, it is highly likely that replacing Y13 (in
SRSF3) with K17 in SRSF2 will have a signiﬁcant effect
on the afﬁnity of SRSF2 for RNA.
The amino acids present in the b-sheets are thought to
be non-selective as they are common to all RRM (1).
However, in nature, alternative splicing via SR protein
are known to proceed via selective interaction between
speciﬁc RNA sequences and SR RRM domains. Along
with the b-sheet interactions, the loop region L3 of both
SRSF2 and SRSF3 interact with the RNA. In the case of
SRSF3, the L3 loop comprises four residues including two
prolines that contribute to a relatively well constrained
short loop region. SRSF2, however, consists of nine
amino acids which are shown here by NMR relaxation
studies to be relatively ﬂexible. The ﬂexibility and length
of SRSF2 L3 may explain why it was difﬁcult to observe a
high number of intermolecular NOEs. In addition the
longer length of the RNA used here in SRSF2 binding
was necessary to obtain a high-afﬁnity complex,
compared to the much shorter 4-mer RNA for SRSF3
which was chosen for the quality of the resultant NMR
spectra rather than for its afﬁnity to SRSF3 (16). The
C-terminus residues of both SRSF2 and SRSF3 provide
binding interactions to the 30-end of the RNA (G7)
through residue N82 of SRSF3 and Y92 of SRSF2. The
N-termini interactions found in SRSF2 namely V10-RNA
(G7) are also consistent with K11–RNA interaction
identiﬁed in SRSF3-CAUC complex although this inter-
action was not satisﬁed in the ﬁnal structure reported for
the SRSF3–CAUC complex, due possibly to the truncated
nature of the RNA used. It is possible that with a longer
RNA sequence might make more contacts with the RRM
domain of SRSF3, similar to the ones observed here.
In summary, our results show that the ﬂexible L3 loop
of SRSF2 together with its ﬂexible N- and C-termini col-
lectively provide the necessary binding sites for the RNA
interaction
DISCUSSION
Roles of loop regions of SRSF2 key to RNA interaction
The structure of SRSF2 exhibits the classic RRM-SR
protein fold comprising a four-strand anti-parallel
b-sheet and two a-helices. The L3 loop region between
b-stands 2 and 3 of all the SR-RRM domains shown in
Figure 2 are of variable lengths, with L3 in SRSF2 being
Figure 4. SRSF2:RNA UV cross-linking. Various puriﬁed proteins (BSA, GB1-6His-SRSF2 9-101 wild-type and point mutants) were incubated with
32P-labelled 9-mer RNA (AGCAGAGUA) before binding reactions were irradiated with UV (+) or not () and analysed by 15% SDS–PAGE
stained with Coomassie and autoradiography.
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somewhat longer and highly ﬂexible. RNA binding to
SRSF2 was initially probed by interaction with a 5-mer
RNA identiﬁed by SELEX. Although this sequence bound
favorably when compared to control 5-mers selected on
purine/pyrimidine composition, the resultant interaction
was of low afﬁnity with Kd of the order of 10
4 M. The
extension of the sequence to the 9-mer, again based on
SELEX, increased the afﬁnity to the order of 108 M.
Changes in chemical shifts of SRSF3 upon binding the
9-mer AGCAGAGUA RNA showed that SRSF3 binds
RNA with the expected features, involving the b-sheet and
loop regions.
The importance of the L3 loop is most interesting; this
appears to be a primary site since it is the region whose
chemical shifts are most affected upon addition of both
the weak-binding 5-mer GAGUA and the 9-mer AGCAG
AGUA. The mutagenesis studies also demonstrate that L3
residues such as R47, D48 and K52 are responsible for
mediating SRSF2 binding to the RNA. Other structural
and mutagenesis studies of RRM–RNA interactions have
previously highlighted that the loop regions can play im-
portant roles in RNA recognition although which and
how many loops are important is protein speciﬁc (37).
Focusing on the L3 loop (b2–b3 loop), in human
RBMY this loop is required for the recognition of the
shape of the RNA, based on the fact that all the loop
residues contact the phosphate backbone (38). In the
case of SRSF2, the side chains D48 and Y50 form inter-
molecular NOEs with the G2 nucleotide base; this
together, with the signiﬁcant effects of mutagenesis,
suggests that L3 has a role in nucleotide recognition.
In many RRM–RNA structures, an aromatic residue
present in loop L1 (b1–a1 loop) is crucial for RRM–
RNA interactions. For example, the F126 of Fox-1
RRM is important for binding the 50-end of the RNA
(39). The equivalent residue in SRSF2 is Y23. Only a
modest reduction is afﬁnity for RNA was observed
when Fox-1 F126 was mutated to a tyrosine residue,
implying that Y23 in SRSF2 could, in principle, play a
similar role in RNA binding as F126 in Fox-1.
Surprisingly, the NMR resonances of Y23 of SRSF2
were not affected upon RNA binding and no intermolecu-
lar NOEs involving Y23 were observed (Supplementary
Figure S5). In addition, SRSF3, like many other SR
proteins, have no equivalent aromatic residues in loop 1.
This suggests that for the SR family of RRM domains,
loop 1 is not involved in RNA binding.
The results here show that SRSF2 binds RNA using
features which are found in other RRM–RNA inter-
actions, namely, via the canonical b-sheet binding
Figure 5. Isothermal titration calorimetry curves for WT and K52A mutant ﬁt to a one-site model. (A) WT SRSF2 with AGCAGAGUA (25mM
PO4
3-, 25mM KCl, 25C) curve ﬁtting to a one-site 1:1 model yields ﬁt parameters: N (stoichiometry ratio)=1.03, Kd=6.17 108M,
H=21.3 kcal/mol and S=38.4 calmol1K1. (B) K52A SRSF2 with AGCAGAGUA (25mM PO43-, 25mM KCl, 25C), curve ﬁtting to
a one-site model yields ﬁt parameters: N=0.953, Kd=1.63 107M, H=30 kcal/mol and S=69.5 calmol1K1.
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interface and the crucial involvement of one loop region,
that is, the L3 loop.
This change from an aromatic to a basic residue
between the SR proteins could potentially be one of
the factors which determine RNA sequence selectivity. A
comparison between the low-resolution SRSF2-9-mer AG
CAGAGUA RNA model structure from the cluster, with
the structures of SRSF3:CAUC (and Fox-1:UGCAUGU)
supports the variability of RRM–RNA interactions that
are known to exist (Supplementary Figure S8).
Non-speciﬁc standard RRM interactions are present
A comparison with the structure of SRSF3 bound to a
4-nt RNA highlight that non-speciﬁc standard RRM
interactions are present on the solvent-exposed face of
the b-sheet of SRSF2. In particular, in both the SRSF2-
and SRSF3–RNA complexes, the well-conserved F57 and
F59 are shown to be involved in interactions with the
counterpart RNA. However, these interactions alone are
insufﬁcient. In the case of SRSF3-CAUC, the Y13 in b1
provides that additional stabilizing interactions with C1.
Figure 6. (A) NOEs used to derive the model of SRSF2–RRM bound to 9-mer AGCAGAGUA RNA; V10-Ade6, D48-Gua2, Y50-Gua2 and
Y92-Uri8. (B) Left: Ensemble of 10 structures from CNS calculations that contribute to the lowest energy cluster. (C) Left: Ensemble of ﬁve
structures from CNS calculations that contribute to the second cluster. In both (B) and (C) the mobility of loop 3 and terminal regions afford a great
degree of freedom to the orientation of the RNA. Right: representative structure (closest to mean) from each cluster with side chain residues shown
for the incorporated intermolecular NOEs. In addition conserved hydrophobic residues F57 and F59 (pale yellow) are found to be involved in the
binding.
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In SRSF2, Y13 is replaced by a lysine in the equivalent
position (K17). The loss of one of the most conserved
aromatic residues in the RNP2 motif provides the
possible explanation as to why SRSF2 is only able to
bind a 5-mer RNA weakly, and that longer RNA frag-
ments such as the 9-mer are necessary in order to provide
additional protein–RNA contacts to stabilize the SRSF2–
RNA complex.
We characterized the thermodynamics of the 9-mer
interactions with SRSF3 using isothermal titration calor-
imetry. This interaction represents an interaction between
a RRM domain and an unstructured single stranded
RNA. There are very few examples in the literature of
the thermodynamics analyses of the interactions between
RRM domains and unstructured RNAs. In several
reported cases, these interactions have been accompanied
by very large favorable enthalpy changes (30 to
60 kcalmol1) and unfavorable entropy changes,
and these have been conﬁrmed to be of physiological
signiﬁcance (40). The enthalpic and entropic changes for
SRSF2–RNA interactions reported here are more modest
(H=21 kcal/mol TS=11.43 calmol1K1)
although still signiﬁcant and larger than average
protein–protein interactions. The large enthalpy and
entropy changes observed for many of the RRM–RNA
interactions are attributed to the extensive p stacking
interactions involving aromatic residues in b1 and b3
whose positions are structurally conserved to afford
these hydrophobic interactions with the nucleotides. In
SRSF2, as discussed above, the b1 aromatic residue is
missing, hence, providing a possible explanation for the
smaller H and S.
Restraint-driven model of SRSF2-9-mer AGCAGAGUA
RNA complex suggests different mode of binding
The limited number of intermolecular contacts, plus the
fact that these are between poorly structured, ﬂexible
regions of both the SRSF2–RRM and the RNA,
precluded the calculation of a high-resolution structure
of the complex. However, models could be obtained
from the limited intermolecular NOE data and chemical
shift perturbations using the CNS software which
produced an ensemble of the water-reﬁned structures in
which all the experimental restraints were satisﬁed.
Pairwise RMSD analysis of the ensemble structures
showed that the ensemble could be split into two
clusters, using a cutoff of 5 A˚ (Figure 6B and C). These
two clusters are quite similar with variation between them
being <7 A˚. In these models, the backbone of the nucleo-
tides 2–4 of the RNA are aligned parallel to the b-strands
with multiple orientations for the 50 (proximal to loop 3)
and 30 (proximal to the N- and C-termini) end nucleotides.
The variation between the two clusters is minimal (RMSD
of <7 A˚) for structured regions. The two clusters resolve
below 5 A˚ and appear to arise due to differing local envir-
onments for G2 and A4. In the ﬁrst cluster (Figure 6B),
the orientations for loop 3 seem restricted due to G2 in
close proximity to T51 (and restrained by G2-Y50 NOE).
In the second cluster (Figure 6C) positioning of G2
appears more varied with orientation of A4 more
restricted in close proximity to Y44 of b-strand 2. In
both clusters, it is evident that A1 and G2 interact with
L3, and the residues of the N- and C-termini (namely V10
and Y92) are in close contacts with 50-end of the RNA. In
addition, nucleotides C3 and A4 are located adjacent to
the b-sheet.
In summary, it is possible, even with these
low-resolution models, to discern the orientation of the
RNA with respect to the RRM, which highlight a different
orientation of the RNA relative to the protein when
compared with SRSF3 and other RRM–RNA complexes.
The models show A1 and G2 interacting with L3, and the
residues V10 and Y92 in close contacts with 50-end of the
RNA. It is posited that the mode of interaction obtained
here is due to the longer length of the RNA forming more
points of contacts with the SRSF2 RRM domains
(involving loop 3, and also the C- and N-termini)
leading to the different RNA orientation relative to the
RRM domain.
The results here show that the ﬂexible L3 loop of
SRSF2 together with its ﬂexible N- and C-termini collect-
ively provide the necessary binding sites for the RNA
interaction. The ﬂexibility and variability of loop 3
residues and C- and N-termini between SR family
members could provide the selectivity required for the
alternative splicing pathways targeted by different family
members. Many structural RRM:RNA binding studies
use small RNA fragments to facilitate ease of analysis;
however, the results here show that longer RNA frag-
ments are necessary in the case of SRSF2 in order to
obtain better afﬁnity, with binding afforded by the collab-
orative effects of two binding areas. Therefore, studies
involving both longer RNA fragments and the N/C
residues beyond the consensus RRM domain may
provide further insights into the selectivity of the RRM
binding in SR proteins.
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